Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function

Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function

Show other versions (1)

Background: Colistimethate sodium (CMS) treatment has increased over the last years, being acute kidney injury (AKI) its main drug-related adverse event. Therefore, this study aimed to evaluate the incidence and risk factors associated with AKI, as well as identifying the factors that determine rena...

Full description

Bibliographic Details
Main Authors: Saúl Pampa-Saico, Vicente Pintado, Alfonso Muriel, Fernando Caravaca-Fontan, Estefanía Yerovi-León, Aurora Rojo-Sanchis, José M. del Rey, M. Teresa Tenorio, Fernando Liaño
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Nefrología (English Edition)
Subjects:
Colistimetato de sodio
Enfermedad renal crónica
Fracaso renal agudo
Online Access:http://www.sciencedirect.com/science/article/pii/S2013251420301449

Internet

http://www.sciencedirect.com/science/article/pii/S2013251420301449

Similar Items